Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 6,276 | N/A | N/A |
| Marketable Securities | 1,850 | N/A | N/A |
| Other current assets | 595 | 0 | 0 |
| TOTAL | $8,771 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 955 | N/A | N/A |
| Other Non-Current Assets | 850 | 0 | 0 |
| TOTAL | $1,805 | $N/A | $N/A |
| Total Assets | $10,576 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 601 | 0 | 0 |
| Accrued Expenses | 1,237 | N/A | N/A |
| Other current liabilities | 6 | N/A | N/A |
| TOTAL | $1,848 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 6,000 | N/A | N/A |
| Other Non-Current Liabilities | 34,554 | 0 | 0 |
| TOTAL | $40,558 | $N/A | $N/A |
| Total Liabilities | $42,406 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 66 | N/A | N/A |
| Retained earnings | -37,520 | N/A | N/A |
| Other shareholders' equity | 2,504 | 0 | 0 |
| TOTAL | $-31,830 | $N/A | $N/A |
| Total Liabilities And Equity | $10,576 | $0 | $0 |